Soiken Holdings Inc
TSE:2385
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| JP |
|
Soiken Holdings Inc
TSE:2385
|
6.8B JPY |
Loading...
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
203B EUR |
Loading...
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
116B GBP |
Loading...
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.5T INR |
Loading...
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
36.1B GBP |
Loading...
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
37.9B USD |
Loading...
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
23B EUR |
Loading...
|
|
| JP |
|
Kao Corp
TSE:4452
|
3.1T JPY |
Loading...
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR |
Loading...
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
899.9B INR |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
Market Distribution
| Min | -179.8% |
| 30th Percentile | 21.8% |
| Median | 30.6% |
| 70th Percentile | 42.3% |
| Max | 18 197.9% |
Other Profitability Ratios
Soiken Holdings Inc
Glance View
Soiken Holdings Inc. is engaged in the development of biomarkers and assessment systems. The company is headquartered in Toyonaka-Shi, Osaka-Fu and currently employs 104 full-time employees. The company went IPO on 2003-12-18. The firm operates in six business segments. The Biological Evaluation System segment is engaged in evaluation test of food and research support of medicine. The Healthcare Support segment is engaged in the provision of service about certain health guidance and healthcare insurance. The Cosmetics segment is engaged in manufacturing and sales of cosmetics. The Dietary Supplements segment is engaged in sales of unique dietary supplements. The Marketing segment is engaged in the marketing research of health supplement and sales of energy drink. The Functional Material Development segment is engaged in development and sales of functional materials, such as lactoferrin.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Soiken Holdings Inc is 48.5%, which is above its 3-year median of 47.7%.
Over the last 3 years, Soiken Holdings Inc’s Gross Margin has increased from 46.5% to 48.5%. During this period, it reached a low of 45.7% on Mar 31, 2023 and a high of 50.3% on Mar 31, 2025.
